PAVmed (PAVM) Return on Capital Employed (2016 - 2025)

PAVmed has reported Return on Capital Employed for 10 years, with the latest figure at 92.39% in Q4 2025.

• For the quarter ending Q4 2025, Return on Capital Employed fell 74146.0% year-over-year to 92.39%; the trailing twelve-month figure through Dec 2025 stood at 92.39% (down 74146.0% YoY), and the FY2025 full-year result was 109.58%, down 136045.0% from the prior year.
• Return on Capital Employed for Q4 2025 stood at 92.39%, down from 66.16% in the prior quarter.
• The five-year high for Return on Capital Employed was 1157.5% in Q3 2023, with the low at 1010.82% in Q1 2023.
• Average Return on Capital Employed over 5 years is 26.81%, with a median of 93.56% recorded in 2025.
• Peak annual rise in Return on Capital Employed reached 139988 bps in 2023, while the deepest fall reached 91406 bps in 2023.
• Tracing PAVM's Return on Capital Employed over 5 years: stood at 94.73% in 2021, then tumbled by 337 bps to 413.61% in 2022, then surged by 200 bps to 414.25% in 2023, then jumped by 57 bps to 649.07% in 2024, then slumped by 114 bps to 92.39% in 2025.
• The last three Return on Capital Employed figures came in at 92.39% (Q4 2025), 66.16% (Q3 2025), and 76.7% (Q2 2025), per Business Quant data.

Peer Comparison